Earnings ·
NRC Health reported second quarter 2026 financial results, announcing Total Recurring Contract Value (TRCV) of $151.9…
NRCNrc Health
NRC Health reported second quarter 2026 financial results, announcing Total Recurring Contract Value (TRCV) of $151.9 million, an 11% year-over-year increase. Total revenue reached $35.4 million, up 4% from the prior year. The company reported a GAAP net loss of $3.3 million, or $0.15 per diluted share, while Adjusted Net Income was $6.9 million, or $0.31 per diluted share. Adjusted EBITDA stood at $9.4 million, representing a 27% margin. Additionally, the Board declared a quarterly cash dividend of $0.16 per share, payable on October 9, 2026, to shareholders of record as of September 25, 2026. NRC Health operates in the healthcare industry, providing experience improvement solutions, market research, and governance services to healthcare organizations.